Aquestive Therapeutics Inc. (AQST) is priced at $0.93 after the most recent trading session. At the very opening of the session, the stock price was $0.94 and reached a high price of $0.94, prior to closing the session it reached the value of $0.90. The stock touched a low price of $0.90.Recently in News on November 15, 2022, Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences. Aquestive Therapeutics, Inc. (Nasdaq: AQST), a pharmaceutical company advancing current standards of care to solve patients’ problems through simplifying complex delivery methods, announced today that the management team will participate in the two upcoming investor conferences as follows:. You can read further details here
Aquestive Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $4.2900 on 01/03/22, with the lowest value was $0.6180 for the same time period, recorded on 07/01/22.
Aquestive Therapeutics Inc. (AQST) full year performance was -84.49%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Aquestive Therapeutics Inc. shares are logging -85.48% during the 52-week period from high price, and 50.32% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.62 and $6.40.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 339533 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Aquestive Therapeutics Inc. (AQST) recorded performance in the market was -76.12%, having the revenues showcasing -40.06% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 49.51M, as it employees total of 157 workers.
Market experts do have their say about Aquestive Therapeutics Inc. (AQST)
During the last month, 6 analysts gave the Aquestive Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.0758, with a change in the price was noted +0.21. In a similar fashion, Aquestive Therapeutics Inc. posted a movement of +29.03% for the period of last 100 days, recording 692,659 in trading volumes.
Technical breakdown of Aquestive Therapeutics Inc. (AQST)
Raw Stochastic average of Aquestive Therapeutics Inc. in the period of last 50 days is set at 20.19%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 35.16%. In the last 20 days, the company’s Stochastic %K was 30.48% and its Stochastic %D was recorded 37.07%.
Bearing in mind the latest performance of Aquestive Therapeutics Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -76.12%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -6.16%, alongside a downfall of -84.49% for the period of the last 12 months. The shares increased approximately by -9.81% in the 7-day charts and went down by 1.75% in the period of the last 30 days. Common stock shares were lifted by -40.06% during last recorded quarter.